Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Pfizer submits application for COVID booster dose in children ages 5-11
In This Article:
Yahoo Finance Live reports on Pfizer submitting its application for children to receive a third COVID-19 vaccine dose.
Video Transcript
BRAD SMITH: We've got some breaking news to get to as Pfizer has filed a formal application to the US Food and Drug Administration for an EUA, Emergency Use Authorization, for a booster dose for children of the community vaccine, children 5 through 11 years of age. You're tracking shares there on your screen of PFE. Right now, fractionally lower. We'll keep close tabs on shares of Pfizer here.
Terms and Privacy Policy